On June 9, the District Court registered the increase of the capital of BRASTER S.A., which means that its shares listed on NewConnect and shares from the new issue may debut on the main market of the Warsaw Stock Exchange this month. BRASTER obtained gross PLN 39 million from the public offering. The funds will allow BRASTER to fully implement the strategy aimed at offering the Braster device for direct sale to women in the second half of 2016.

After the increase, the share capital of the Company amounts to PLN 561,465.30 and is divided into 5,614,653 shares of A, B, C, D, E, and F series which will be admitted to trading on the regulated market. The planned change of the quotation market should take place this month.

BRASTER S.A. successfully sold all 2.6 million new series F shares, obtaining gross PLN 39 million from investors (including the cost of issue). The obtained funds will be allocated to building a technology line, developing the final, commercial version of the device for women, creating a system for the automatic interpretation of thermographic examinations received from the Braster device, and completing the work related to placing the product on the market.

In November last year, the Company presented its new strategy for 2015–2021, according to which the Braster device will be addressed directly to women, and will be placed on the Polish market in the second half of 2016.

In 2017, its distribution in Germany and the United Kingdom is projected to begin. A year later the device will be placed on the markets of, among others, other European Union countries and the United States.